Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro
Autor: | Anetta Wronska, Heikki Swan, Annukka Marjamaa, Kimmo Kontula, Päivi J. Laitinen-Forsblom, Lauri Toivonen |
---|---|
Rok vydání: | 2009 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent Cardiomyopathy Mutation Missense 030204 cardiovascular system & hematology In Vitro Techniques medicine.disease_cause Catecholaminergic polymorphic ventricular tachycardia Ryanodine receptor 2 Sudden death Sudden cardiac death Membrane Potentials 03 medical and health sciences Young Adult 0302 clinical medicine Risk Factors Internal medicine medicine Missense mutation Humans Family cardiovascular diseases 030304 developmental biology Aged 0303 health sciences Mutation business.industry Ryanodine receptor Ryanodine Receptor Calcium Release Channel Middle Aged medicine.disease 3. Good health Pedigree Endocrinology Death Sudden Cardiac Phenotype cardiovascular system Tachycardia Ventricular Female Cardiology and Cardiovascular Medicine business Cardiomyopathies |
Zdroj: | International journal of cardiology. 147(2) |
ISSN: | 1874-1754 |
Popis: | Background Catecholaminergic polymorphic ventricular tachycardia caused by mutations in the RyR2 gene manifests as severe arrhythmias, and may provide a candidate for sudden cardiac deaths. Methods We screened 19 victims of SCD for mutations in the RyR2 gene by direct sequencing, and analyzed DNAs from available family members and from 300 controls. Medico-legal investigations were conducted by experienced pathologists. We performed resting ECG, cardiac ultrasonography, exercise stress test, epinephrine test and 24-hour ambulatory ECG recording to related mutation carriers ( n =17). The single channel recordings of the mutant RyR2s were conducted in planar lipid bilayers, and the open probabilities were determined by sequential addition of CaCl 2 to the cis -side. Results We identified two novel RyR2 missense mutations (G2145R and R3570W) in three victims of SCD. The surviving carriers of these mutations exhibited only minor, if any structural abnormalities, and two carriers of R3570W showed ventricular arrhythmias predominantly at rest. Single channel recordings revealed a gain-of-function defect in native unphosphorylated R3570W and a similar but milder defect in native G2145R. Conclusions RyR2 mutations manifesting as a gain-of-function defect in vitro may be detectable in some cases of SCD. Not all RyR2 mutations lead to a uniform, highly penetrant CPVT phenotype. |
Databáze: | OpenAIRE |
Externí odkaz: |